Beyond the conventional attention on amyloid beta and tau pathology, researchers are actively discovering promising therapeutic areas for the condition. These feature affecting inflammatory processes through reducing glial function, interacting with neuronal loss – particularly related to excitatory neurotransmitter communication – and assessin